相关实验视频

Updated: Sep 13, 2025

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

通过增强JAM3和PARVB表达,PALB2突变增加了乳腺上皮细胞的致癌性质

Hanna Tuppurainen¹, Marjut Nätynki¹, Niina Laurila¹

¹Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, Biocenter Oulu and Faculty of Medicine, Medical Research Center Oulu, University of Oulu, FI-90220 Oulu, Finland.

Biochemical and biophysical research communications

|July 29, 2025

概括

对于DNA修复至关重要的PALB2基因的突变增强了癌细胞迁移和巨型皮诺细胞分裂. 这些发现揭示了PALB2相关癌症的新治疗点.

科学领域:

遗传学和分子生物学
癌症研究癌症研究
细胞生物学细胞生物学

背景情况:

像PALB2这样的高风险基因中的异构性致病突变通过影响DNA损伤反应,使其易患家族性乳腺癌.
PALB2对于管理基因组,复制和氧化压力,保持基因组完整性和预防癌症至关重要.
虽然已知PALB2突变细胞中的DNA修复缺陷,但其他前瘤特征,特别是早期恶性瘤阶段,需要进一步调查.

研究的目的:

为了研究PALB2-突变细胞的非DNA修复相关的前瘤特征.
确定特定的基因和细胞过程,有助于增强PALB2突变细胞的致癌潜力.
探索PALB2相关癌症的潜在治疗策略.

主要方法:

在非恶性背景下生成双基和单基PALB2突变细胞系.
转录组分析以确定差异表达的基因.
基因淘汰实验 (JAM3,PARVB,PALB2) 用于评估功能影响.
评估细胞迁移,球形形成和巨细胞.
作为巨细胞细胞瘤的标记物,对德克斯吸收的研究及其与DNA损伤的关系.

主要成果:

突变PALB2的细胞表现出增强的迁移能力和改变的球形形成.
在PALB2突变细胞中,JAM3和PARVB的调节显著上升;它们的淘汰减少了迁移和球状形状异常.
在PALB2突变细胞中,巨细胞增强,依赖于β-parvin.
JAM3和PARVB的上调与长期的细胞变化有关,而不是直接通过PALB2敲击或对照细胞中的DNA损伤.
在PALB2突变细胞中,DNA损伤增加了核右的积累,这表明核酸补充用于修复.

结论:

在DNA修复缺陷之外,PALB2突变通过多种机制赋予了增强的致癌潜力,包括增加的迁移和巨细胞分裂.
在PALB2-突变细胞中,JAM3和PARVB是迁移和形态变化的关键媒介.
在PALB2突变细胞中增强的巨细胞酶可以为DNA修复提供核酸,将细胞代谢与基因组稳定性联系起来.
这些发现为PALB2相关癌症提供了新的治疗点.

关键词:

细胞迁移细胞迁移遗传性乳腺癌是一种遗传性乳腺癌.在MCF10A细胞中.巨型皮诺细胞形成症致癌转变的致癌性转变在TGFβ中,TGFβ是TGFβ.

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...